Evidence map›Paper›PMID 40975857›Full record

ArticleMolecular diversity2026

TMolNet: a task-aware multimodal neural network for molecular property prediction.

Cao Han, Xianghong Tang, Jianguang Lu

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cao HanState Key Laboratory of Public Big Data, Guizhou University, 550025 Huaxi District, Guiyang, 550025, Guizhou, China. gs.chan23@gzu.edu.cn.
Xianghong TangState Key Laboratory of Public Big Data, Guizhou University, 550025 Huaxi District, Guiyang, 550025, Guizhou, China.
Jianguang LuState Key Laboratory of Public Big Data, Guizhou University, 550025 Huaxi District, Guiyang, 550025, Guizhou, China.

Funding

Guizhou Provincial Key Technology Research and Development Program of China QKHZC[2022]YB074Guizhou Provincial Major Scientific and Technological Program of China QKHZDZX[2022]001
6 · The paper itself

Abstract

Molecular property prediction plays a vital role in drug discovery, materials science, and chemical biology. Although molecular data are intrinsically multimodal-comprising 1D sequences or fingerprints, 2D topological graphs, and 3D geometric conformations-conventional approaches often rely on single-modal inputs, thereby failing to leverage cross-modal complementarities and limiting predictive accuracy. To overcome this limitation, we propose TMolNet, a task-aware deep learning framework for adaptive multimodal fusion. The architecture integrates modality-specific feature extractors to learn distinct representations from 1D, 2D, and 3D inputs, reducing the bias caused by incomplete or under-represented modalities. A contrastive learning scheme aligns the representations across modalities within a shared latent space, enhancing semantic consistency. Furthermore, a novel task-aware gating module dynamically modulates the contribution of each modality based on both data characteristics and task requirements. To promote balanced modality usage during training, we introduce a modality entropy regularization loss, which encourages diversity and stability in learned representations. Comprehensive experimental results on multiple benchmark datasets show that TMolNet achieves competitive performance against existing advanced methods in predictive accuracy and generalization. These findings underscore the efficacy of our approach and advance the state-of-the-art in multimodal molecular property prediction.

Indexed as

Neural Networks, ComputerAlgorithmsDeep LearningDrug DiscoveryGraph neural networksMolecular property predictionMolecular representationMultimodal fusion

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.